CG Oncology, Inc. (CGON) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for CG Oncology, Inc. (CGON): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 35/100 — a percentile rank of CG Oncology, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $6.1B |
| P / S | 972.8× |
| EV / EBITDA | -24.2× |
| Gross margin | -85.2% |
| Operating margin | -4056.2% |
| Net margin | -3602.7% |
| Return on equity | -21.8% |
| ROIC | -25.0% |
| Revenue growth | 1030.3% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Independent of the events above — derived from CG Oncology, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact